{
  "id": 18760995,
  "title": "Japan OK’s insurance coverage of Alzheimer’s drug lecanemab",
  "url": "https://urgent.news/2026/11/07/japan-oks-insurance-coverage-of-alzheimers-drug-lecanemab",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-07T08:10:43.000Z",
  "source": {
    "name": "The Japan News by The Yomiuri Shimbun",
    "slug": "the-japan-news-by-the-yomiuri-shimbun",
    "url": "https://japannews.yomiuri.co.jp/news-services/jiji-press/20261107-357767/"
  },
  "original_language": "en",
  "account": null,
  "summary": "TOKYO (Jiji Press) — An advisory panel to the health minister on Friday approved public health insurance coverage for an injection version of lecanemab, an Alzheimer’s medicine developed by Eisai Co. and Biogen Inc., and its administration at patients’ homes, effective Nov. 13.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}